Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Effect of Panretinal Photocoagulation on Optic Nerve Head Topography
Effect of Panretinal Photocoagulation on Optic Nerve Head Topography and Nerve Fiber Layer Parameters
Status: Enrolling
Updated:  10/6/2008
University of Nebraska Medical Center Eye Clinic
mi
from
Omaha, NE
Effect of Panretinal Photocoagulation on Optic Nerve Head Topography
Effect of Panretinal Photocoagulation on Optic Nerve Head Topography and Nerve Fiber Layer Parameters
Status: Enrolling
Updated: 10/6/2008
University of Nebraska Medical Center Eye Clinic
mi
from
Omaha, NE
Click here to add this to my saved trials
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration
Status: Enrolling
Updated:  10/22/2008
Eagle Mountain Vision
mi
from
Tulsa, OK
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration
Status: Enrolling
Updated: 10/22/2008
Eagle Mountain Vision
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration
Study Investigating High Resolution OCT, Multifocal ERG and Microperimetry Outcomes of Monthly vs As Needed Ranibizumab in Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  11/25/2008
Retina Macula Institute
mi
from
Torrance, CA
Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration
Study Investigating High Resolution OCT, Multifocal ERG and Microperimetry Outcomes of Monthly vs As Needed Ranibizumab in Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 11/25/2008
Retina Macula Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated:  11/26/2008
Pacific Eye Specialists
mi
from
San Francisco, CA
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated: 11/26/2008
Pacific Eye Specialists
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated:  11/26/2008
Hunkeler Eye Institute
mi
from
Overland Park, KA
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated: 11/26/2008
Hunkeler Eye Institute
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated:  11/26/2008
Minnesota Eye Consultants, PA
mi
from
Minneapolis, MN
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated: 11/26/2008
Minnesota Eye Consultants, PA
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated:  11/26/2008
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract
Status: Enrolling
Updated: 11/26/2008
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Randomized, Investigator Masked Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Status: Enrolling
Updated:  12/2/2008
North Bay Eye Associates
mi
from
Petaluma, CA
Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Randomized, Investigator Masked Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Status: Enrolling
Updated: 12/2/2008
North Bay Eye Associates
mi
from
Petaluma, CA
Click here to add this to my saved trials
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated:  1/20/2009
Bascom Palmer Eye Insitute
mi
from
Miami, FL
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated: 1/20/2009
Bascom Palmer Eye Insitute
mi
from
Miami, FL
Click here to add this to my saved trials
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated:  1/20/2009
Bascom Palmer of the Palm Beaches
mi
from
Palm Beach Gardens, FL
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated: 1/20/2009
Bascom Palmer of the Palm Beaches
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
Status: Enrolling
Updated:  2/4/2009
Bucci Laser Vision & Ambulatory Surgery Center
mi
from
Wilkes-Barre, PA
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
Status: Enrolling
Updated: 2/4/2009
Bucci Laser Vision & Ambulatory Surgery Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Status: Enrolling
Updated:  2/10/2009
Southern New England Retina Associates
mi
from
Providence, RI
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Status: Enrolling
Updated: 2/10/2009
Southern New England Retina Associates
mi
from
Providence, RI
Click here to add this to my saved trials
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated:  2/10/2009
Fichte,Endl, & Elmer EyeCare
mi
from
Amherst, NY
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated: 2/10/2009
Fichte,Endl, & Elmer EyeCare
mi
from
Amherst, NY
Click here to add this to my saved trials
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated:  2/10/2009
The Ira G. Ross Eye Institute
mi
from
Buffalo, NY
Treatment of Keratoconus Using Collagen Cross-Linking
Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.
Status: Enrolling
Updated: 2/10/2009
The Ira G. Ross Eye Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients
Status: Enrolling
Updated:  2/17/2009
Florida Eye Microsurgical Institute
mi
from
Boynton Beach, FL
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients
Status: Enrolling
Updated: 2/17/2009
Florida Eye Microsurgical Institute
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Comprehensive Evaluation of Visual Function
Comprehensive Evaluation of Visual Function
Status: Enrolling
Updated:  5/5/2009
The Chicago Lighthouse
mi
from
Chicago, IL
Comprehensive Evaluation of Visual Function
Comprehensive Evaluation of Visual Function
Status: Enrolling
Updated: 5/5/2009
The Chicago Lighthouse
mi
from
Chicago, IL
Click here to add this to my saved trials
Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)
A Pilot Study of a Sustained-Release Fluocinolone Implant for Treatment of Retinal Vein Occlusion
Status: Enrolling
Updated:  8/4/2009
Duke University Eye Center
mi
from
Durham, NC
Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)
A Pilot Study of a Sustained-Release Fluocinolone Implant for Treatment of Retinal Vein Occlusion
Status: Enrolling
Updated: 8/4/2009
Duke University Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion
A Pilot Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion
Status: Enrolling
Updated:  8/4/2009
Duke Eye Center
mi
from
Durham, NC
A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion
A Pilot Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion
Status: Enrolling
Updated: 8/4/2009
Duke Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
I-ZIP Ocular Bandage Pivotal Study
Clinical Evaluation of the I-ZIP® Ocular Bandage as a Protective Ocular Bandage in Subjects Undergoing Clear Corneal Cataract Surgery With IOL Implantation: A Pivotal Study
Status: Enrolling
Updated:  8/7/2009
I-Therapeutix, Inc.
mi
from
Waltham, MA
I-ZIP Ocular Bandage Pivotal Study
Clinical Evaluation of the I-ZIP® Ocular Bandage as a Protective Ocular Bandage in Subjects Undergoing Clear Corneal Cataract Surgery With IOL Implantation: A Pivotal Study
Status: Enrolling
Updated: 8/7/2009
I-Therapeutix, Inc.
mi
from
Waltham, MA
Click here to add this to my saved trials
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated:  8/14/2009
Department of Ophthalmology, Mount Sinai School of Medicine
mi
from
New York, NY
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 8/14/2009
Department of Ophthalmology, Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Tears Substitutions and Their Effects on Higher Order Aberrometery
Tears Substitutions and Their Effects on Higher Order Aberrometery
Status: Enrolling
Updated:  9/24/2009
University of Iowa Department of Ophthalmology and Visual Sciences
mi
from
Iowa City, IA
Tears Substitutions and Their Effects on Higher Order Aberrometery
Tears Substitutions and Their Effects on Higher Order Aberrometery
Status: Enrolling
Updated: 9/24/2009
University of Iowa Department of Ophthalmology and Visual Sciences
mi
from
Iowa City, IA
Click here to add this to my saved trials
Evaluation of Pascal Laser Trabeculoplaty
Prospective Evaluation of the Efficacy of Pascal Trabeculoplasty: A Pilot Study
Status: Enrolling
Updated:  9/28/2009
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Evaluation of Pascal Laser Trabeculoplaty
Prospective Evaluation of the Efficacy of Pascal Trabeculoplasty: A Pilot Study
Status: Enrolling
Updated: 9/28/2009
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
Status: Enrolling
Updated:  10/22/2009
Rocky Mountain Lions Eye Institute
mi
from
Aurora, CO
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
Status: Enrolling
Updated: 10/22/2009
Rocky Mountain Lions Eye Institute
mi
from
Aurora, CO
Click here to add this to my saved trials
Partnership for Glaucoma
Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership
Status: Enrolling
Updated:  12/9/2009
University of Alabama at Birmingham
mi
from
Birmingham, AL
Partnership for Glaucoma
Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership
Status: Enrolling
Updated: 12/9/2009
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Partnership for Glaucoma
Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership
Status: Enrolling
Updated:  12/9/2009
Duke University
mi
from
Durham, NC
Partnership for Glaucoma
Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership
Status: Enrolling
Updated: 12/9/2009
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Epithelial Healing and Visual Outcomes Using Omega-3 Therapy Before and After Photorefractive Keratectomy (PRK) Surgery
Epithelial Healing and Visual Outcomes of Patients Using Omega-3 Supplements as an Adjunct Therapy Before and After Photorefractive Keratectomy (PRK) Surgery
Status: Enrolling
Updated:  1/28/2010
UCSD Shiley Eye Center
mi
from
La Jolla, CA
Epithelial Healing and Visual Outcomes Using Omega-3 Therapy Before and After Photorefractive Keratectomy (PRK) Surgery
Epithelial Healing and Visual Outcomes of Patients Using Omega-3 Supplements as an Adjunct Therapy Before and After Photorefractive Keratectomy (PRK) Surgery
Status: Enrolling
Updated: 1/28/2010
UCSD Shiley Eye Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Status: Enrolling
Updated:  2/19/2010
University of Missouri-Columbia, Mason Eye Institute
mi
from
Columbia, MO
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Status: Enrolling
Updated: 2/19/2010
University of Missouri-Columbia, Mason Eye Institute
mi
from
Columbia, MO
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Vitreous Associates
mi
from
Beverly Hills, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Vitreous Associates
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
University of California San Diego
mi
from
LaJolla, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
University of California San Diego
mi
from
LaJolla, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Doheny Eye Institute
mi
from
Los Angeles, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Doheny Eye Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
East Bay Retina Institute
mi
from
Oakland, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
East Bay Retina Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Macula Institute
mi
from
Torrance, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Macula Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Institute of Hawai'i
mi
from
Honolulu, HI
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Institute of Hawai'i
mi
from
Honolulu, HI
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Illinois Retina Associates
mi
from
Joliet, IL
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Illinois Retina Associates
mi
from
Joliet, IL
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
University of Kansas
mi
from
Prairie Village, KA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
University of Kansas
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Johns Hopkins University Wilmer Eye Institute
mi
from
Baltimore, MD
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Johns Hopkins University Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Eye Care Specialists
mi
from
Kingston, PA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Eye Care Specialists
mi
from
Kingston, PA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Black Hills Eye Institute
mi
from
Rapid City, SD
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Black Hills Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Texas Retina Associates
mi
from
Arlington, TX
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Texas Retina Associates
mi
from
Arlington, TX
Click here to add this to my saved trials
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated:  4/1/2010
School of Optometry, University of Alabama at Birmingham
mi
from
Birmingham, AL
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated: 4/1/2010
School of Optometry, University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated:  4/1/2010
Yale Eye Center, Yale University
mi
from
New Haven, CT
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated: 4/1/2010
Yale Eye Center, Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated:  4/1/2010
Synabridge Corp.
mi
from
Raritan, NJ
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated: 4/1/2010
Synabridge Corp.
mi
from
Raritan, NJ
Click here to add this to my saved trials
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated:  4/1/2010
Edward S. Harkness Eye Institute, Columbia University
mi
from
New York, NY
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated: 4/1/2010
Edward S. Harkness Eye Institute, Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated:  4/1/2010
Hamilton Eye Institute, The University of Tennessee
mi
from
Memphis, TN
Instrument for Glaucoma Early Detection and Monitoring
SBIR II Instrument for Glaucoma Early Detection and Monitoring
Status: Enrolling
Updated: 4/1/2010
Hamilton Eye Institute, The University of Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
Antioxidant Systems and Age-Related Macular Degeneration
Antioxidant Systems and Age-Related Macular Degeneration
Status: Enrolling
Updated:  4/22/2010
Vanderbilt Eye Institute
mi
from
Nashville, TN
Antioxidant Systems and Age-Related Macular Degeneration
Antioxidant Systems and Age-Related Macular Degeneration
Status: Enrolling
Updated: 4/22/2010
Vanderbilt Eye Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated:  5/25/2010
Bay Area Retina Associates
mi
from
Castro Valley, CA
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated: 5/25/2010
Bay Area Retina Associates
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated:  5/25/2010
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated: 5/25/2010
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated:  5/25/2010
Georgia Retina
mi
from
Riverdale, GA
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated: 5/25/2010
Georgia Retina
mi
from
Riverdale, GA
Click here to add this to my saved trials
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated:  5/25/2010
Retina Vitreous Associates
mi
from
Toledo, OH
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.
Status: Enrolling
Updated: 5/25/2010
Retina Vitreous Associates
mi
from
Toledo, OH
Click here to add this to my saved trials